Updated

Scientists studying a decades-old leukemia drug found that removing a protein called NUDT5 protected cells from the drug's effects, even though directly blocking the protein alone had little impact. The unexpected finding points to a previously hidden cellular role that may explain variable patient responses to certain leukemia treatments. The discovery could help guide more personalized approaches to leukemia therapy based on individual cellular biology.